No Data
No Data
No Data
No Data
No Data
常茂生物:年報 2023
Futu NewsApr 19 05:03 ET · Announcements
Changmao Biotech (00954.HK) received 1.98 million shares from Chairman Rui Xinsheng
Gelonghui, April 8 | According to the latest equity disclosure data of the Stock Exchange, from April 2 to April 3, 2024, Changmao Biotech (00954.HK) was granted a total increase of 1.8 million shares by executive director Rui Xinsheng (Chairman) at an average price of HK$0.3796-0.38 per share on the market, involving about HK$750,000. After increasing its holdings, Rui Xinsheng's latest shareholding was 9.34 million shares, and the shareholding ratio increased from 4.01% to 5.08%.
Gelonghui FinanceApr 7 18:46 ET
Market Cool On Changmao Biochemical Engineering Company Limited's (HKG:954) Revenues Pushing Shares 28% Lower
To the annoyance of some shareholders, Changmao Biochemical Engineering Company Limited (HKG:954) shares are down a considerable 28% in the last month, which continues a horrid run for the company.
Simply Wall StMar 27 19:55 ET
Changmao Biotech (00954) announced annual results. Shareholders' losses of 86.057 million yuan were converted from profit to loss year-on-year
Changmao Biotech (00954) announced its annual results for the year ended December 31, 2023. The group received revenue...
Zhitong FinanceMar 26 09:13 ET
CHANGMAO BIO: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 26 09:09 ET · Announcements
SDIC Securities: The food and beverage industry is resilient and clearly actively recommends companies with changing competitiveness during the off-peak season
China Investment Securities believes that sector valuations are still at the bottom, excellent companies can still have excess profits, and continue to recommend the sector.
Zhitong FinanceMar 3 19:17 ET
No Data
No Data